A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study Evaluating the Safety and Efficacy of Pirfenidone Solution for Inhalation (AP01) in Subjects with Progressive Pulmonary Fibrosis (PPF)

  • Khoo, JK (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date31/10/24 → 31/10/26

Keywords

  • clinical trial
  • Pulmonary Fibrosis
  • Pirfenidone
  • immune response